On February 10, 2025, Miao Wei, Secretary of the Party Committee and Chairman of Chengdu Industrial Investment Group Co., Ltd. (hereinafter referred to as "Chengdu Industrial Investment"), and his entourage visited Sichuan Jiuzhang Biotechnology Co., Ltd. (hereinafter referred to as "Jiuzhang Biotech"), where they engaged in a discussion and exchange. The purpose of this visit is to further promote the high-quality development of Chengdu's biomedical industry and assist in the transformation and industrialization of scientific and technological achievements.

Zhang Jie, the Chairman of Jiuzhang Biotech, introduced the company's development history, core technologies, and future plans to Miao Wei and his entourage. He focused on presenting the R&D situation of the chlorogenic acid bulk pharmaceutical chemicals sourced from natural plants of the company, as well as the company's product plans and development needs. He also expressed gratitude for the attention and support given by Chengdu Industrial Group.

During the symposium, the two sides had an in-depth discussion on possible future cooperation directions. Miao Wei pointed out that Chengdu Industrial Group will give full play to the leveraging effect of state-owned capital and support the further development of Jiuzhang Biotech in the field of natural medicine research and development through means such as fund investment and industrial carrier construction. Zhang Jie stated that Jiuzhang Biotech will also rely on the resource support from various aspects to accelerate the industrialization process of the globally first-in-class new drug project of chlorogenic acid for injection.